Latest / The Onco Life Podcast
New Targeted Drug sac-TMT Improves Survival in Advanced Endometrial Cancer
A new targeted cancer drug called sac-TMT is showing promising results for patients with advanced or recurrent endometrial cancer. In a major Phase 3 clinical trial, the treatment improved both overall survival and progression-free survival compared with standard chemotherapy after previous treatments stopped working.In this episode, we break down the latest TroFuse-005 trial results, how antibody-drug conjugates work, and why this development could change future treatment options for advanced endometrial cancer.You’ll learn: What does advanced and recurrent endometrial cancer mean Why do…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.